ES2539722T3 - Compuesto de tetrahidrobenzotiofeno - Google Patents

Compuesto de tetrahidrobenzotiofeno Download PDF

Info

Publication number
ES2539722T3
ES2539722T3 ES11775050.5T ES11775050T ES2539722T3 ES 2539722 T3 ES2539722 T3 ES 2539722T3 ES 11775050 T ES11775050 T ES 11775050T ES 2539722 T3 ES2539722 T3 ES 2539722T3
Authority
ES
Spain
Prior art keywords
alkyl
aryl
alkylene
substituted
coo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11775050.5T
Other languages
English (en)
Inventor
Shunichiro Hachiya
Masanori Miura
Yoshimasa Imamura
Daisuke Kaga
Ippei Sato
Hiroyuki Moritomo
Koji Kato
Kazuhiro Terai
Yoh Terada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ES2539722T3 publication Critical patent/ES2539722T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de la fórmula (I) o una sal del mismo:**Fórmula** [en donde R1 representa -O-alquilo C1-C6, -alquilen C1-6-fenilo, o -alquilen C1-C6-piridilo (en donde fenilo o piridilo pueden estar sustituidos con carboxi o -CO-O-alquilo C1-C6, -CO-O-alquenilo C1-C6, -CO-O-alquinilo C1-C6, -CO-O-alquileno C1-C6-O-alquilo C1-C6, -CO-O-alquilen C1-C6-arilo, -CO-O-alquilen C1-C6-O-arilo, -CO-NH2, -CO-NH-alquilo C1-C6, -CO-N(alquilo C1-6)2, -CO-N(alquil C1-C6)arilo, -CO-N(alquil C1-C6)-(alquileno C1-C6- arilo), -CO-NH-alquileno C1-C6-OH, -CO-NH-alquileno C1-C6-CO2H, -CO-O-metilo, -CO-O-etilo, o -COO-terc-butilo), R2 y R3 son iguales o diferentes entre sí y representan -H, alquilo C1-C6, cicloalquilo, arilo, heteroarilo, heteroanillo saturado que contiene nitrógeno, -alquilen C1-C6-arilo, o -alquilen C1-C6-heteroarilo (en donde alquilo C1-C6, cicloalquilo, arilo, heteroarilo y heterociclo saturado que contiene nitrógeno pueden estar sustituidos con halógeno, -alquilo C1-C6, piridilo, carboxi, -CO-O-alquilo C1-C6, -CO-O-alquenilo C1-C6, -CO-O-alquinilo C1-C6, -CO-O-alquilen C1-C6-O-alquilo C1-C6, -CO-O-alquilen C1-C6-arilo, -CO-O-alquilen C1-C6- O-arilo, -CO-NH2, -CO-NH-alquilo C1-C6, -CO-N(alquilo C1-C6)2, -CO-N(alquil C1-C6)arilo, -CO-N(alquil C1- C6)-(alquilen C1-C6-arilo), -CO-NH-alquilen C1-C6-OH, -CO-NH-alquilen C1-C6-CO2H, -CO-O-metilo, -CO-O-etilo, -COO-terc-butilo, amino que puede estar sustituido con un grupo -alquilo C1-C6, o los mismos o diferentes dos o más -alquilo C1-C6, -O-alquilo C1-C6, -[CH(-OH)]m-H, u -OH), o R2 y R3 se pueden combinar con un átomo de nitrógeno al que están unidos para formar un amino cíclico saturado de 5 a 7 miembros (en donde el amino cíclico saturado de 5 a 7 miembros que puede estar sustituido con halógeno, -OH, oxo (>= O), -O-alquilo C1-C6, ciano, nitro, cicloalquilo, arilo, heteroanillo, - alquilen C1-C6-arilo, alquileno C1-C6-heteroanillo, -alquilo C1-C6 (que puede estar sustituido con halógeno, - OH, -O-alquilo C1-C6, o ciano), carboxi, -CO-O-alquilo C1-C6, -COO-alquenilo C1-C6, -CO-O-alquinilo C1-C6, -CO-O-alquilen C1-C6-O-alquilo C1-C6, -CO-O-alquilen C1-C6-arilo, -CO-O-alquilen C1-C6-O-arilo, -CO-NH2, - CO-NH-alquilo C1-C6, -CO-N(alquilo C1-C6)2, -CO-N(alquil C1-C6)arilo, -CO-N(alquil C1-C6)-(alquilen C1-C6- arilo), -CO-NH-alquilen C1-C6-OH, -CO-NH-alquilen C1-C6-CO2H, -CO-O-metilo, -CO-O-etilo, -COO-terc-butilo o -CO-alquil C1-C6), los R4' son iguales o diferentes entre sí y representan halógeno, alquilo C1-C6, -OH, -O-alquilo C1-C6, -NO2, o un grupo representado por la fórmula (II): **Fórmula**
ES11775050.5T 2010-04-28 2011-04-27 Compuesto de tetrahidrobenzotiofeno Active ES2539722T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010104044 2010-04-28
JP2010104044 2010-04-28
PCT/JP2011/060261 WO2011136269A1 (ja) 2010-04-28 2011-04-27 テトラヒドロベンゾチオフェン化合物

Publications (1)

Publication Number Publication Date
ES2539722T3 true ES2539722T3 (es) 2015-07-03

Family

ID=44861567

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11775050.5T Active ES2539722T3 (es) 2010-04-28 2011-04-27 Compuesto de tetrahidrobenzotiofeno

Country Status (15)

Country Link
US (3) US20130029973A1 (es)
EP (1) EP2565190B1 (es)
JP (1) JP5617919B2 (es)
KR (1) KR101721025B1 (es)
CN (1) CN102869656B (es)
AU (1) AU2011246072B2 (es)
BR (1) BR112012025390B8 (es)
CA (1) CA2793856C (es)
EA (1) EA022521B1 (es)
ES (1) ES2539722T3 (es)
MX (1) MX2012012421A (es)
PH (1) PH12012501851A1 (es)
PL (1) PL2565190T3 (es)
PT (1) PT2565190E (es)
WO (1) WO2011136269A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2565190T3 (pl) 2010-04-28 2015-10-30 Astellas Pharma Inc Związek tetrahydrobenzotiofenowy
ES2585415T3 (es) * 2011-10-27 2016-10-05 Astellas Pharma Inc. Derivado de N-tienilbenzamida sustituida con aminoalquilo
WO2013129435A1 (ja) * 2012-02-28 2013-09-06 協和発酵キリン株式会社 縮環チオフェン誘導体
WO2014003153A1 (ja) * 2012-06-28 2014-01-03 協和発酵キリン株式会社 置換アミド化合物
US9499553B2 (en) 2013-03-13 2016-11-22 Chugai Seiyaku Kabushiki Kaisha Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same
PT2975030T (pt) * 2013-03-13 2020-09-28 Chugai Pharmaceutical Co Ltd Derivado de di-hidropiridazina-3,5-diona
TWI594975B (zh) * 2013-04-24 2017-08-11 第一三共股份有限公司 二羧酸化合物
WO2015064532A1 (ja) * 2013-10-30 2015-05-07 第一三共株式会社 モルホリン化合物
WO2016026372A1 (zh) * 2014-08-22 2016-02-25 江苏恒瑞医药股份有限公司 噻吩并环烷基或噻吩并杂环基类衍生物、其制备方法及其在医药上的应用
NZ729640A (en) * 2014-09-12 2022-04-29 Chugai Pharmaceutical Co Ltd Pharmaceutical containing sodium-dependent phosphate transporter inhibitor
BR112017005694A2 (pt) * 2014-09-26 2017-12-12 Daiichi Sankyo Co Ltd cristais de um sal, ou hidrato do mesmo, cristais de um trihidrato de sal dissódico, composição farmacêutica, uso dos cristais, e, método para prevenção ou tratamento de hiperfosfatemia.
CN105524053B (zh) * 2014-10-19 2020-06-05 广东东阳光药业有限公司 四氢苯并噻吩化合物
TW201700458A (zh) * 2015-04-24 2017-01-01 第一三共股份有限公司 二羧酸化合物之製法
SI3497091T1 (sl) * 2016-08-15 2020-11-30 Eli Lilly And Company Kondenzirani derivati tiofena uporabni kot inhibitorji NAPI-IIB
WO2020102889A1 (en) * 2018-11-19 2020-05-28 Fouda Ahmed 4,5,6,7-tetrahydro-l-benzothiophene modulators of retinoic acid receptor related (rar) orphan nuclear receptors (rors)
AR126060A1 (es) 2021-06-08 2023-09-06 Chugai Pharmaceutical Co Ltd Método para producir derivado de dihidropiridazin-3,5-diona
KR20240018523A (ko) 2021-06-08 2024-02-13 추가이 세이야쿠 가부시키가이샤 다이하이드로피리다진-3,5-다이온 유도체를 함유하는 제제
WO2023219127A1 (ja) 2022-05-11 2023-11-16 中外製薬株式会社 嚢胞性疾患を治療または予防するための医薬組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007131532A (ja) * 2001-09-28 2007-05-31 Kirin Brewery Co Ltd 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
AU2002354410A1 (en) 2001-12-05 2003-06-17 Japan Tobacco Inc. Triazole compound and medicinal use thereof
IL154306A0 (en) 2003-02-05 2003-09-17 Rimonyx Pharmaceuticals Ltd Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
WO2004085382A1 (ja) 2003-03-27 2004-10-07 Kirin Beer Kabushiki Kaisha 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
EP1670804A2 (en) 2003-09-10 2006-06-21 GPC Biotech AG Heterobicyclic compounds as pharmaceutically active agents
US20050085531A1 (en) 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
WO2006093518A2 (en) 2004-06-25 2006-09-08 Apath, Llc Thienyl compounds for treating virus-related conditions
AU2005279845A1 (en) 2004-08-30 2006-03-09 Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Inhibition of viruses using RNase H inhibitors
JP2008517061A (ja) 2004-10-20 2008-05-22 コンパス ファーマシューティカルズ リミティド ライアビリティ カンパニー 抗腫瘍剤としての化合物及びそれらの使用
GB0514652D0 (en) 2005-07-15 2005-08-24 Syngenta Ltd Pesticidal mixtures
WO2009079373A2 (en) 2007-12-14 2009-06-25 The Regents Of The University Of California Inhibitors of calcium-activated chloride channels
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
AU2009203549B2 (en) 2008-01-08 2013-03-07 Purdue Pharma L.P. Proline Analogs as ligands for cannabinoid receptors for the treatment of pain
BRPI0914254A2 (pt) 2008-06-17 2015-11-03 Inst Nat Sante Rech Med compostos anti-infectivos
PL2565190T3 (pl) 2010-04-28 2015-10-30 Astellas Pharma Inc Związek tetrahydrobenzotiofenowy
WO2012006475A1 (en) 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport

Also Published As

Publication number Publication date
US20130053369A1 (en) 2013-02-28
PT2565190E (pt) 2015-08-24
EP2565190A1 (en) 2013-03-06
EA022521B1 (ru) 2016-01-29
JPWO2011136269A1 (ja) 2013-07-22
PL2565190T3 (pl) 2015-10-30
CA2793856C (en) 2018-07-17
CN102869656B (zh) 2014-03-12
US20140329802A1 (en) 2014-11-06
AU2011246072A1 (en) 2012-10-11
BR112012025390A2 (pt) 2016-06-28
WO2011136269A1 (ja) 2011-11-03
US20130029973A1 (en) 2013-01-31
JP5617919B2 (ja) 2014-11-05
CN102869656A (zh) 2013-01-09
PH12012501851A1 (en) 2013-02-04
MX2012012421A (es) 2012-12-17
US8729068B2 (en) 2014-05-20
BR112012025390B1 (pt) 2021-10-13
AU2011246072B2 (en) 2014-06-26
CA2793856A1 (en) 2011-11-03
KR20130073908A (ko) 2013-07-03
BR112012025390B8 (pt) 2022-11-22
KR101721025B1 (ko) 2017-03-29
EP2565190B1 (en) 2015-06-03
EA201291121A1 (ru) 2013-04-30
US9284295B2 (en) 2016-03-15
EP2565190A4 (en) 2013-08-21

Similar Documents

Publication Publication Date Title
ES2539722T3 (es) Compuesto de tetrahidrobenzotiofeno
DOP2011000061A (es) Compuestos de pirrol
CO6241101A2 (es) Derivados de quinolina como inhibidores de la p13 quinasa
GT200700036A (es) Compuestos fenil amido heterociclicos condensados
EA201600241A1 (ru) Замещенные (2r,3r,5r)-3-гидрокси-(5-пиримидин-1-ил)тетрагидрофуран-2-илметил арил фосфорамидаты
PE20142081A1 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos
EA201491598A1 (ru) Композиция для борьбы с вредителями, включающая новое производное иминопиридина
AR079634A1 (es) Inhibidores del virus de la hepatitis c
AR072166A1 (es) Derivado de piperidina y su uso como inhibidor de renina superior
CO6260076A2 (es) Derivados de uracilo o timina para el tratamiento de la hepatitis c
DOP2010000272A (es) Nuevos derivados de carbazol inhibidores de hsp90, composiciones que los contienen y utilizacion
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
PE20141041A1 (es) Compuestos, metodos y formulaciones parasiticidas
ECSP12011760A (es) Estabilizante de amina estéricamente inhibida
EA201391637A1 (ru) Ингибиторы вируса гепатита c
CO6801736A2 (es) Derivados heterocíclicos de amina
CO6140056A2 (es) Compuestos amino -5-4(difluorometoxi)fenil sustituido-5-fenilimidazolona como inhibidores de beta -secretasa
CO2020003114A2 (es) Compuesto que tiene estructura ciclica
ECSP14013296A (es) Derivados de etinilo
AR082619A1 (es) Inhibidores del virus de la hepatitis c
CO6341610A2 (es) Compuesto heterociclilo aromatico que contiene nitrogeno.
PE20141940A1 (es) Compuestos triciclicos, composiciones que los comprenden y usos de los mismos
AR082111A1 (es) Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas
EA201391717A1 (ru) Ингибиторы вируса гепатита с